Paiote (688177.SH): The application for market approval of Vedolizumab Injection (BAT5906) has been accepted.

Zhimedia Finance App News: BioAtai (688177.SH) has released an announcement that the company has recently received the "Acceptance Notice" issued by the National Medical Products Administration regarding the company's application for the market approval of its investigational drug Vilasitumab Vedotin injection (referred to as "BAT5906").